Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results

Rhea-AI Summary

Kindred Biosciences, Inc. (NASDAQ: KIN) will announce its fourth quarter and full year 2020 financial results on March 16, 2021, after market close. A conference call will follow at 4:30 p.m. ET, accessible via toll-free number (855) 433-0927 or internationally at (484) 756-4262. The call will also be available as a live webcast. Kindred Biosciences focuses on developing safe and effective biologics for pets, utilizing targets that are already validated in humans. The company boasts a robust pipeline and advanced manufacturing capabilities.

SAN FRANCISCO, March 8, 2021 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will release its fourth quarter and full year 2020 financial results on March 16, 2021, after the market close. The Company will host a conference call at 4:30 p.m. Eastern time/1:30 p.m. Pacific time that day.

Access the call by dialing toll-free (855) 433-0927 from the U.S. or (484) 756-4262 internationally, and using conference ID 3989605.

The call will also be webcast live here, with a replay available at that link for 30 days.

About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.

For more information, visit: www.kindredbio.com

Contact
Katja Buhrer 
katja.buhrer@kindredbio.com 
(917) 969-3438

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-fourth-quarter-and-full-year-2020-financial-results-301241668.html

SOURCE Kindred Biosciences, Inc.

FAQ

When will Kindred Biosciences release its financial results?

Kindred Biosciences will release its financial results for the fourth quarter and full year 2020 on March 16, 2021.

What time is the Kindred Biosciences conference call?

The conference call for Kindred Biosciences will be held at 4:30 p.m. Eastern Time on March 16, 2021.

How can I access the Kindred Biosciences conference call?

You can access the Kindred Biosciences conference call by dialing (855) 433-0927 in the U.S. or (484) 756-4262 internationally.

Will there be a replay of the Kindred Biosciences conference call?

Yes, a replay of the Kindred Biosciences conference call will be available for 30 days following the event.

What is the focus of Kindred Biosciences?

Kindred Biosciences focuses on developing innovative biologics aimed at improving pet health, using proven targets from human medicine.